IRIDEX Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 108

Employees

  • Stock Symbol
  • IRIX

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.69
  • (As of Friday Closing)

IRIDEX General Information

Description

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Contact Information

Website
www.iridex.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1212 Terra Bella Avenue
  • Mountain View, CA 94043
  • United States
+1 (650)
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 1212 Terra Bella Avenue
  • Mountain View, CA 94043
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IRIDEX Stock Performance

As of 13-Nov-2026, IRIDEX’s stock price is $0.69. Its current market cap is $12.1M with 17.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.69 $0.71 $0.61 - $1.65 $12.1M 17.6M 383K -$0.20

IRIDEX Financials Summary

As of 30-Jun-2026, IRIDEX has a trailing 12-month revenue of $51.6M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 25,611 24,809 28,997 40,571
Revenue 51,573 52,675 48,669 51,869
EBITDA (1,873) (2,833) (7,418) (7,448)
Net Income (3,547) (4,437) (8,910) (9,570)
Total Assets 27,258 29,151 29,135 34,436
Total Debt 4,013 4,532 4,643 2,746
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IRIDEX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IRIDEX‘s full profile, request access.

Request a free trial

IRIDEX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough
Other Devices and Supplies
Mountain View, CA
108 As of 2025

Geneva, Switzerland
 

Kent Town, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IRIDEX Competitors (16)

One of IRIDEX’s 16 competitors is Alcon, a Corporate Backed or Acquired company based in Geneva, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alcon Corporate Backed or Acquired Geneva, Switzerland
Nova Eye Medical Corporation Kent Town, Australia
Medtronic Corporation Minneapolis, MN
Glaukos Formerly VC-backed Aliso Viejo, CA
Stryker Formerly VC-backed Portage, MI
You’re viewing 5 of 16 competitors. Get the full list »

IRIDEX Patents

IRIDEX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4812136-A1 Sector probe system for the delivery of laser energy Pending 22-Nov-2023
US-20250161115-A1 Sector probe system for the delivery of laser energy Pending 22-Nov-2023
WO-2025111548-A1 Sector probe system for the delivery of laser energy Inactive 22-Nov-2023
US-12465522-B2 Methods and probes for intrascleral laser surgery Active 07-Dec-2020
US-20220175580-A1 Methods and probes for intrascleral laser surgery Active 07-Dec-2020 A61F9/00736
To view IRIDEX’s complete patent history, request access »

IRIDEX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IRIDEX Investments & Acquisitions (3)

IRIDEX’s most recent deal was a Corporate Asset Purchase with Topcon (Pascal Laser Product Line). The deal was made on 10-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Topcon (Pascal Laser Product Line) 10-Mar-2021 Corporate Asset Purchase Buildings and Property
Topcon Medical Laser Systems 10-Mar-2021 Merger/Acquisition Diagnostic Equipment
RetinaLabs (Ophthalmology Line) 08-Apr-2010 Merger/Acquisition Surgical Devices
To view IRIDEX’s complete investments and acquisitions history, request access »

IRIDEX ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

33.36 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view IRIDEX’s complete esg history, request access »

IRIDEX FAQs

  • When was IRIDEX founded?

    IRIDEX was founded in 1989.

  • Where is IRIDEX headquartered?

    IRIDEX is headquartered in Mountain View, CA.

  • What is the size of IRIDEX?

    IRIDEX has 108 total employees.

  • What industry is IRIDEX in?

    IRIDEX’s primary industry is Other Devices and Supplies.

  • Is IRIDEX a private or public company?

    IRIDEX is a Public company.

  • What is IRIDEX’s stock symbol?

    The ticker symbol for IRIDEX is IRIX.

  • What is the current stock price of IRIDEX?

    As of 13-Nov-2026 the stock price of IRIDEX is $0.69.

  • What is the current market cap of IRIDEX?

    The current market capitalization of IRIDEX is $12.1M.

  • What is IRIDEX’s current revenue?

    The trailing twelve month revenue for IRIDEX is $51.6M.

  • Who are IRIDEX’s competitors?

    Alcon, Nova Eye Medical, Medtronic, Glaukos, and Stryker are some of the 16 competitors of IRIDEX.

  • What is IRIDEX’s annual earnings per share (EPS)?

    IRIDEX’s EPS for 12 months was -$0.20.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process